Nexstim Plc updates the timeline for its supplementary E-FIT Phase III Trial in Stroke Rehabilitation
Helsinki, Finland: 19 May 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, today provided a timeline update for its supplemental Phase III clinical trial in stroke rehabilitation, known as E-FIT (ELECTRIC FIELD NAVIGATED 1HZ RTMS FOR POST-STROKE MOTOR RECOVERY TRIAL).
The trial began enrolment in March of 2017. Start-up issues at some of the enrolling sites have created a slight delay in the enrolment rate and Nexstim now expects the E-FIT trial to be completed in Q2 2018. This change in timing has no significant impact on the costs associated with the E-FIT trial.
More info on Nexstim's website.
Next > New Chairman of the Board will accelerate US growth
Previous > NGDATA acquires Eccella to fuel international growth and expansion